Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancer (Q61651053)
Jump to navigation
Jump to search
scientific article published on 01 April 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancer |
scientific article published on 01 April 2000 |
Statements
Doubling of the epirubicin dosage within the 5-fluorouracil, epirubicin and cyclophosphamide regimen: a prospective, randomized, multicentric study on antitumor effect and quality of life in advanced breast cancer (English)
A Riccardi
S Brugnatelli
P Pugliese
V Giardina
M Giordano
M Danova
A Richetti
S Fava
E Rinaldi
V Fregoni
G Trotti